THE HIGHLIGHT

THE HIGHLIGHT

MOSTLY READ

MOSTLY READ

EMALEX BIOSCIENCES ACQUIRES PSYADON PHARMACEUTICALS

Feb 17, 2019

Paragon Biosciences’ portfolio company Emalex Biosciences has acquired fellow USA-based Psyadon Pharmaceuticals, a biopharmaceutical company dedicated to the development of new … Read more

CORPORATE STRATEGY

Feb 17, 2019

Leverage agile frameworks to provide a robust synopsis for high level overviews. Iterative approaches to corporate strategy foster collaborative thinking to … Read more

EMALEX BIOSCIENCES ACQUIRES PSYADON PHARMACEUTICALS

Jan 20, 2019

EMALEX BIOSCIENCES ACQUIRES PSYADON PHARMACEUTICALS TO DEVELOP NOVEL TREATMENT FOR PEDIATRIC TOURETTE SYNDROME CHICAGO – August 14, 2018 Biopharmaceutical company Emalex … Read more

BLUE MOUNTAIN CAPPUCCINO CAFFEINE BEANS

Jan 10, 2019

Dripper iced carajillo affogato coffee redeye cortado mug cultivar grinder robust. Frappuccino arabica irish froth redeye, at siphon sit aromatic barista. … Read more

Post 1

Dec 16, 2018

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Paragon company buys biotech with treatment for pediatric Tourette syndrome

May 6, 2018

Paragon Biosciences’ portfolio company Emalex Biosciences has acquired fellow USA-based Psyadon Pharmaceuticals, a biopharmaceutical company dedicated to the development of new … Read more